COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors.

Antonio TanzilliAndrea PaceGennaro CilibertoAntonia Marina La MalfaValentina BuonomoDario BenincasaAnnamaria BiscuEdvina GalièVeronica Villani

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)

The COVID-19 vaccine is safe and well tolerated in PBT patients.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
binding protein